Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...

Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Explore Metagene-1 AI, the advanced system transforming pandemic prevention and bioweapon defense with real-time genetic ...

Debut, the biotech beauty leader, announced today the launch of BeautyORB™, an AI-powered innovation engine that provides a ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

BRUSSELS: Artificial intelligence (AI), biotech and affordable clean energy will be the focus of a European Union (EU) drive ...

In a paper published in Nature Biotechnology, three Stanford University-affiliated co-authors, including Stanford Law School ...